Home
>
White Papers
>
Clinical Development
Clinical Development
Levamisole, An Orphan Drug for the Treatment of Nephrotic Syndrome
On 28 October 2005, orphan designation (EU/3/05/324) was granted by the European Commission to ACE Pharmaceuticals BV, The Netherlands,...
Clinical Development White Papers
Levamisole, An Orphan Drug for the Treatment of Nephrotic Syndrome
»10 Aug 06
»Submitted by
ACE Pharmaceuticals
Home
|
New On This Site
|
Industry Projects
|
Products & Services
|
Jobs & Careers
|
Press Releases
|
Newsletter
|
Events & Exhibitions
|
Organisations
|
Advertise With Us
Copyright
2008 SPG Media Limited a subsidiary of SPG Media Group PLC
Home
Industry Projects
Products & Services
Company A-Z
White Papers
Jobs & Careers
Press Releases
Advertise With Us
Events & Exhibitions
Newsletter
New On This Site
About Us
What is RSS?